Skip to content
Evigrade
MajorAntifungals, triazole derivatives×SNRI (serotonin-norepinephrine reuptake inhibitor)

Updated · Methodology

Mechanism

In the liver, CYP2D6 converts venlafaxine mainly into the active metabolite O-desmethylvenlafaxine, and CYP3A4 converts a smaller part into a less active metabolite. Venlafaxine and its metabolites are excreted mainly by the kidneys (venlafaxine SmPC). Fluconazole moderately inhibits CYP3A4 and strongly inhibits CYP2C19, and this effect lasts 4–5 days after fluconazole is stopped (fluconazole SmPC). CYP3A4 inhibitors may raise levels of venlafaxine and its active metabolite. With ketoconazole, the venlafaxine area under the concentration–time curve (AUC) rose by 21% in people with normal CYP2D6 activity and by 70% in those with low activity (venlafaxine SmPC). The documents describe no study with fluconazole. Both drugs are linked to QT prolongation. Fluconazole prolongs the QT interval by blocking a potassium current in heart cells (fluconazole SmPC). With venlafaxine, QT prolongation and ventricular arrhythmias have been reported after marketing, especially in overdose or in people with other risk factors (venlafaxine SmPC).

Symptoms

QT prolongation itself causes no symptoms and shows only on an electrocardiogram (ECG). Torsade de pointes causes palpitations, dizziness or fainting. With fluconazole, QT prolongation and torsade de pointes have been reported very rarely, and the cases included seriously ill people with multiple risk factors. Low potassium and advanced heart failure raise the risk of life-threatening ventricular arrhythmias (fluconazole SmPC). Higher venlafaxine levels may increase the risk of its adverse reactions (Effexor XR label, US Food and Drug Administration, FDA). The most common adverse reactions of venlafaxine are nausea, dry mouth, headache and sweating. Venlafaxine raises blood pressure and heart rate more at higher doses (venlafaxine SmPC).

Management

Avoid combining venlafaxine with drugs that prolong the QT interval (venlafaxine SmPC). According to its own SmPC, fluconazole prolongs the QT interval (fluconazole SmPC). Fluconazole is contraindicated with drugs that prolong QT and are metabolised by CYP3A4, such as cisapride, astemizole, pimozide, quinidine and erythromycin (fluconazole SmPC). Venlafaxine is not on this list. Use fluconazole with caution in people with potentially proarrhythmic conditions. Low potassium and advanced heart failure raise the risk of life-threatening arrhythmias (fluconazole SmPC). In people at high risk of serious arrhythmia or QT prolongation, weigh the benefit and risk before prescribing venlafaxine (venlafaxine SmPC). Use venlafaxine with caution together with CYP3A4 inhibitors (venlafaxine SmPC), which include fluconazole (fluconazole SmPC). The US Food and Drug Administration (FDA) advises considering a lower venlafaxine dose (Effexor XR label, FDA). The enzyme-inhibiting effect of fluconazole persists for 4–5 days after the drug is stopped (fluconazole SmPC). Check blood pressure before starting venlafaxine and regularly during treatment, especially after a dose increase (venlafaxine SmPC).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Fluconazole

Other interactions with Venlafaxine